On June 3, 2026, Elsevier officially released the 2025 CiteScore data. As one of the core metrics for measuring journal academic impact in the international academic community, the annual update of CiteScore objectively reflects the academic dissemination capability and disciplinary development level of journals in recent years.

This year, a total of 5 Open Exploration journals indexed in Scopus have demonstrated outstanding performance, with multiple indicators showing upward trends. Among them, Exploration of Medicine (EM) and Exploration of Targeted Anti-tumor Therapy (ETAT) both ranked in the Q2 quartile in their respective disciplines. EM has achieved significant improvements in both score and ranking, while ETAT has entered the Q2 quartile in oncology for the first time, achieving an annual increase of 74.19% in its score, rising to 5.4. Exploration of Immunology (EI) and Exploration of Neuroprotective Therapy (ENT) have both maintained consecutive year-over-year growth, demonstrating their development potential in their respective fields. The newly indexed journal Exploration of Foods and Foodomics (EFF) has received its first CiteScore of 2.4, marking a significant milestone. Below is the detailed information of the CiteScores for 5 journals.

Exploration of Medicine (EM)

The 2025 CiteScore of Exploration of Medicine rose to 2.9, a year-on-year increase of 61.11% from 1.8 in 2024, maintaining its Q2 position in General Medicine. Ranked 207th among 669 journals in the field, EM climbed 60 places compared to the previous year, reflecting substantial improvements in citation levels and overall academic quality. The journal focuses on innovative clinical and basic medical research in general medicine and is now indexed in authoritative databases including Scopus, Google Scholar, DOAJ, and CAS. Welcome to submit at: https://em.aressystem.com/.

Exploration of Targeted Anti-tumor Therapy (ETAT)

The 2025 CiteScore of Exploration of Targeted Anti-tumor Therapy reached 5.4, an impressive 74.19% increase from the previous year. For the first time, ETAT entered the Q2 quartile in Oncology, ranking 140th among 428 journals in the field—a breakthrough development. The journal focuses on frontiers of targeted therapy and clinical translational research, and is indexed in Scopus, PubMed/PMC, Google Scholar, and other authoritative databases. ETAT’s CiteScore has maintained continuous growth for four consecutive years (1.7 in 2022 → 2.8 in 2023 → 3.1 in 2024 → 5.4 in 2025), steadily enhancing its academic influence with sustained support from its editorial board, reviewers, and authors. Welcome to submit at: https://etat.aressystem.com.

Exploration of Immunology (EI)

The 2025 CiteScore of Exploration of Immunology increased to 1.9, achieving consecutive annual growth (1.0 in 2023 → 1.5 in 2024 → 1.9 in 2025). This upward trend indicates continuous improvement in the journal’s academic quality and reader engagement, highlighting its development potential in the field of immunology. EI focuses on fundamental immunology and mechanisms of immune diseases, publishing high-quality academic outputs, and is indexed in Scopus, Google Scholar, DOAJ, CAS, and other major databases. Welcome to submit at: https://ei.aressystem.com.

Exploration of Neuroprotective Therapy (ENT)

The 2025 CiteScore of Exploration of Neuroprotective Therapy rose to 2.6, a 30% increase from 2.0 in 2024. ENT specializes in neurodegenerative diseases, neuroprotection, and neurorestoration, with a precise academic focus and rigorous review standards. Indexed in Scopus, Google Scholar, DOAJ, CAS, and other mainstream databases, ENT’s academic influence in neuroscience continues to grow steadily. The journal will remain committed to publishing cutting-edge research in neuroprotection and providing a high-quality communication platform for scholars. Welcome to submit at: https://ent.aressystem.com.

Exploration of Foods and Foodomics (EFF)

Exploration of Foods and Foodomics was indexed in Scopus in June 2025 and received its first-ever CiteScore of 2.4 in this release—a solid foundation for future growth. This milestone recognizes the journal’s publication quality, topic value, and academic standards, which have been acknowledged by an internationally authoritative platform. EFF focuses on the interdisciplinary frontiers of food science and foodomics, contributing to academic innovation and translational outcomes in the food field. It is currently indexed in Scopus, Google Scholar, DOAJ, CAS, and other major databases, with its international academic influence steadily rising. Welcome to submit at: https://eff.aressystem.com.

About the 2025 CiteScore

The CiteScore metric is calculated by dividing the total citations received by all documents published in a journal over a four-year period (including research articles, review articles, conference papers, data papers, and book chapters) by the total number of such documents published during the same period. The 2025 CiteScore covers the citation window from 2022 to 2025. As an important reference for measuring journal academic impact, CiteScore provides an intuitive reflection of a journal's sustained academic contribution and literature dissemination efficiency, while also offering an objective basis for scholars to select journals for submission, track disciplinary hotspots, and evaluate the academic value of research outputs.

Advancing Scholarship, Embracing the Future

The achievements of Open Exploration journals in this year's CiteScore release would not have been possible without the professional support and collective efforts of the editorial board members, peer reviewers, and author community. Moving forward, Open Exploration will continue to uphold rigorous peer review mechanisms, adhere to principles of academic integrity in publishing, further optimize manuscript processing workflows, and enhance the author service experience. We remain committed to publishing high-quality academic achievements, continuously improving our publishing standards and international academic influence.

Open Exploration looks forward to collaborating with more researchers to promote the broad dissemination and sharing of academic achievements.